NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis - Archive ouverte HAL Access content directly
Journal Articles Cellular and Molecular Gastroenterology and Hepatology Year : 2019

NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis

(1) , (2) , (1) , (1, 3) , (2) , (1)
1
2
3

Abstract

Nucleotide-binding oligomerization domain 2 (NOD2) is an intracellular pattern recognition receptor that senses bacterial peptidoglycan-conserved motifs in cytosol and stimulates host immune response including epithelial and immune cells. The association of NOD2 mutations with a number of inflammatory pathologies including Crohn's disease (CD), graft-versus-host diseases, or Blau syndrome, highlights its pivotal role in inflammatory response and the associated-carcinogenesis development. Since its identification in 2001 and its association with CD, the role of NOD2 in epithelial cells and immune cells has been investigated extensively but the precise mechanism by which NOD2 mutations lead to CD and the associated carcinogenesis development is largely unknown. In this review, we present and discuss recent developments about the role of NOD2 inside epithelial cells on the control of the inflammatory process and its linked carcinogenesis development.
Fichier principal
Vignette du fichier
1-s2.0-S2352345X18301553-main.pdf (2 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

inserm-02881522 , version 1 (25-06-2020)

Identifiers

Cite

Audrey Ferrand, Ziad Al Nabhani, Núria Solà Tapias, Emmanuel Mas, Jean-Pierre Hugot, et al.. NOD2 Expression in Intestinal Epithelial Cells Protects Toward the Development of Inflammation and Associated Carcinogenesis. Cellular and Molecular Gastroenterology and Hepatology, 2019, 7 (2), pp.357-369. ⟨10.1016/j.jcmgh.2018.10.009⟩. ⟨inserm-02881522⟩
53 View
69 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More